374 related articles for article (PubMed ID: 19032446)
41. [Therapeutic efficacy of balloon-occluded retrograde transvenous obliteration in patients with gastric variceal bleeding].
Park KS; Kim YH; Choi JS; Hwang JS; Kwon JH; Jang BK; Chung WJ; Cho KB; Ko SM
Korean J Gastroenterol; 2006 May; 47(5):370-8. PubMed ID: 16714879
[TBL] [Abstract][Full Text] [Related]
42. Optimizing logistics for balloon-occluded retrograde transvenous obliteration (BRTO) of gastric varices by doing away with the indwelling balloon: concept and techniques.
Saad WE; Nicholson DB
Tech Vasc Interv Radiol; 2013 Jun; 16(2):152-7. PubMed ID: 23830672
[TBL] [Abstract][Full Text] [Related]
43. Two-year outcomes of balloon-occluded retrograde transvenous obliteration of gastric varices in liver transplant recipients: A multi-institutional study.
Saad WE; Chick JFB; Srinivasa RN; Saad N; Kim S; Fischman A; Frey G; Al-Osaimi A; Caldwell S
Diagn Interv Imaging; 2017 Nov; 98(11):801-808. PubMed ID: 28416166
[TBL] [Abstract][Full Text] [Related]
44. Analysis of prognostic factors in patients with gastric varices after endoscopic treatment.
Wakatsuki T; Obara K; Irisawa A; Sakamoto H; Kuwana T; Takiguchi F; Saito A; Shishido H; Hikichi T; Oyama H; Shibukawa G; Takagi T; Yamamoto G; Imamura H; Takahashi Y; Sato A; Sato M; Kasukawa R; Ohira H
Dig Endosc; 2009 Oct; 21(4):232-8. PubMed ID: 19961521
[TBL] [Abstract][Full Text] [Related]
45. [Long-term results of endoscopic histoacryl (N-butyl-2-cyanoacrylate) injection for treatment of gastric varices--a 10-year experience].
Joo HS; Jang JY; Eun SH; Kim SK; Jung IS; Ryu CB; Kim YS; Kim JO; Cho JY; Kim YS; Lee JS; Lee MS; Shim CS; Kim BS
Korean J Gastroenterol; 2007 May; 49(5):320-6. PubMed ID: 17525520
[TBL] [Abstract][Full Text] [Related]
46. The safety and efficacy of gastric fundal variceal obliteration using N-butyl-2-cyanoacrylate; the experience of a single canadian tertiary care centre.
Mosli MH; Aljudaibi B; Almadi M; Marotta P
Saudi J Gastroenterol; 2013; 19(4):152-9. PubMed ID: 23828744
[TBL] [Abstract][Full Text] [Related]
47. Safe and successful endoscopic initial treatment and long-term eradication of gastric varices by endoscopic ultrasound-guided Histoacryl (N-butyl-2-cyanoacrylate) injection.
Gubler C; Bauerfeind P
Scand J Gastroenterol; 2014 Sep; 49(9):1136-42. PubMed ID: 24947448
[TBL] [Abstract][Full Text] [Related]
48. Endoscopic cyanoacrylate injection for the treatment of bleeding gastric varices: the first Iranian series.
Taghavi SA; Eshraghian A; Hamidpour L; Moshfe MJ
Arch Iran Med; 2012 Mar; 15(3):157-61. PubMed ID: 22369304
[TBL] [Abstract][Full Text] [Related]
49. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores.
Saad WE; Wagner CC; Al-Osaimi A; Bliebel W; Lippert A; Davies MG; Sabri SS; Turba UC; Matsumoto AH; Angle JF; Caldwell S
Vasc Endovascular Surg; 2013 May; 47(4):281-7. PubMed ID: 23681780
[TBL] [Abstract][Full Text] [Related]
50. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis.
Lee SJ; Kim SU; Kim MD; Kim YH; Kim GM; Park SI; Won JY; Lee DY; Lee KH
J Gastroenterol Hepatol; 2017 Aug; 32(8):1487-1494. PubMed ID: 28085232
[TBL] [Abstract][Full Text] [Related]
51. Long-term outcomes of patients with cirrhosis presenting with bleeding gastric varices.
Nakazawa M; Imai Y; Sugawara K; Uchida Y; Saitoh Y; Fujii Y; Uchiya H; Ando S; Nakayama N; Tomiya T; Mochida S
PLoS One; 2022; 17(3):e0264359. PubMed ID: 35290384
[TBL] [Abstract][Full Text] [Related]
52. Clinical outcomes of gastric variceal obliteration using N-butyl-2-cyanoacrylate in patients with acute gastric variceal hemorrhage.
Jun CH; Kim KR; Yoon JH; Koh HR; Choi WS; Cho KM; Lim SU; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
Korean J Intern Med; 2014 Jul; 29(4):437-44. PubMed ID: 25045291
[TBL] [Abstract][Full Text] [Related]
53. Changes in portal systemic pressure gradient after balloon-occluded retrograde transvenous obliteration of gastric varices and aggravation of esophageal varices.
Tanihata H; Minamiguchi H; Sato M; Kawai N; Sonomura T; Takasaka I; Nakai M; Sahara S; Nakata K; Shirai S
Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1209-16. PubMed ID: 19688368
[TBL] [Abstract][Full Text] [Related]
54. Comparison of the Effects of TIPS versus BRTO on Bleeding Gastric Varices: A Meta-Analysis.
Wang ZW; Liu JC; Zhao F; Zhang WG; Duan XH; Chen PF; Yang SF; Li HW; Chen FW; Shi HS; Ren JZ
Can J Gastroenterol Hepatol; 2020; 2020():5143013. PubMed ID: 32104670
[TBL] [Abstract][Full Text] [Related]
55. Proton pump inhibitor administration delays rebleeding after endoscopic gastric variceal obturation.
Jang WS; Shin HP; Lee JI; Joo KR; Cha JM; Jeon JW; Lim JU
World J Gastroenterol; 2014 Dec; 20(45):17127-31. PubMed ID: 25493026
[TBL] [Abstract][Full Text] [Related]
56. Infusion of 50% glucose solution before injection of ethanolamine oleate during balloon-occluded retrograde transvenous obliteration.
Yamagami T; Kato T; Hirota T; Yoshimatsu R; Matsumoto T; Nishimura T
Australas Radiol; 2007 Aug; 51(4):334-8. PubMed ID: 17635469
[TBL] [Abstract][Full Text] [Related]
57. Treatment outcomes after splenectomy with gastric devascularization or balloon-occluded retrograde transvenous obliteration for gastric varices: a propensity score-weighted analysis from a single institution.
Oshita K; Ohira M; Honmyo N; Kobayashi T; Murakami E; Aikata H; Baba Y; Kawano R; Awai K; Chayama K; Ohdan H
J Gastroenterol; 2020 Sep; 55(9):877-887. PubMed ID: 32533300
[TBL] [Abstract][Full Text] [Related]
58. Inventory used for balloon-occluded retrograde (BRTO) and antegrade (BATO) transvenous obliteration: sclerosants and balloon occlusion devices.
Saad WE; Nicholson D; Koizumi J
Tech Vasc Interv Radiol; 2012 Sep; 15(3):226-40. PubMed ID: 23021833
[TBL] [Abstract][Full Text] [Related]
59. [Treatment of extra-esophageal variceal bleeding with cyanoacrylate].
Pécsi G; Kárász T; Rácz I
Orv Hetil; 2007 Mar; 148(11):503-8. PubMed ID: 17350922
[TBL] [Abstract][Full Text] [Related]
60. Efficacy of balloon-occluded retrograde transvenous obliteration, percutaneous transhepatic obliteration and combined techniques for the management of gastric fundal varices.
Arai H; Abe T; Takagi H; Mori M
World J Gastroenterol; 2006 Jun; 12(24):3866-73. PubMed ID: 16804972
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
